InsidersTradesSigma
Total declarations
Companies
▲ Purchases (6 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
6
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+24.9%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by LaFrence Andrew D.C.. Insider active across 3 companies, notably Vyant Bio, Inc.. Cumulatively, 9 reports have been recorded. Split: 6 buys · 0 sell. Total volume traded: €52k. Activity tracked since 20 May 2021. The latest transaction was disclosed on 21 May 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations9 total
11,428 shares@ US$8.75100.0% of flowCommon StockSEC:0001850633-25-000009:0
5,000 shares@ US$1.999550.0% of flowCommon Stock, $0.0001 par valueSEC:0001493152-21-032696
Ideal exit: 20 Aug 2022 (T+270)
5,000 shares@ US$1.999520.4% of flowCommon Stock, $0.0001 par valueSEC:0001493152-21-032696:0
Ideal exit: 20 Aug 2022 (T+270)
5,000 shares@ US$1.999520.4% of flowCommon Stock, $0.0001 par valueSEC:0001493152-21-029829:0
Ideal exit: 20 Aug 2022 (T+270)
5,000 shares@ US$1.999520.4% of flowCommon Stock, $0.0001 par valueSEC:0001493152-21-029829
Ideal exit: 20 Aug 2022 (T+270)
29,292 sharesCommon Stock, $0.0001 par valueSEC:0001493152-21-016687
29,292 sharesCommon Stock, $0.0001 par valueSEC:0001493152-21-016687:0
3,000 shares@ US$3.27918.4% of flowCommon Stock, $0.0001 par valueSEC:0001493152-21-012504:0
Ideal exit: 14 Feb 2022 (T+270)
3,000 shares@ US$3.279100.0% of flowCommon Stock, $0.0001 par valueSEC:0001493152-21-012504
Ideal exit: 14 Feb 2022 (T+270)
9 of 9 declarations
About LaFrence Andrew D.C.
LaFrence Andrew D.C. is a director at Vyant Bio, Inc.
